First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study.
Ann Med
; 55(2): 2243967, 2023.
Article
in En
| MEDLINE
| ID: mdl-37557185
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Bevacizumab
/
Lung Neoplasms
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Ann Med
Journal subject:
MEDICINA
Year:
2023
Document type:
Article
Affiliation country: